Mark S Anderson Selected Research

Autoantigens

3/2022	Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.
11/2021	Single-cell multiomics defines tolerogenic extrathymic Aire-expressing populations with unique homology to thymic epithelium.
1/2020	High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.
1/2020	Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.
1/2020	GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
1/2017	Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity.
12/2016	Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.
6/2015	Transglutaminase 4 as a prostate autoantigen in male subfertility.
4/2015	Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens.
5/2014	Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark S Anderson Research Topics

Disease

15	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 11/2002
11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2005
8	COVID-19 03/2022 - 10/2020
7	Neoplasms (Cancer) 01/2022 - 04/2014
5	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2017 - 11/2006
4	type 1 Autoimmune polyendocrinopathy syndrome 10/2016 - 12/2013
3	Pneumonia (Pneumonitis) 03/2022 - 01/2021
3	Infections 01/2017 - 12/2013
3	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2015 - 12/2009
3	Inflammation (Inflammations) 06/2014 - 01/2008
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2017
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 01/2017
2	Autoimmune Hepatitis 01/2017 - 04/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 05/2012 - 03/2009
2	Dry Eye Syndromes (Dry Eye Syndrome) 04/2010 - 01/2008
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 03/2022
1	COVID-19 related pediatric multisystem inflammatory disease 03/2022
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2022
1	Lipodystrophy 01/2022
1	Panniculitis 01/2022
1	Candidiasis (Moniliasis) 09/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Chronic Pancreatitis 01/2021
1	Asymptomatic Infections 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Margins of Excision 01/2020
1	Adenocarcinoma 01/2019
1	Colitis 01/2019
1	Hereditary pancreatitis 01/2019
1	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 01/2019
1	Pancreatitis 01/2019
1	Rheumatoid Arthritis 01/2018
1	Diabetes Mellitus 01/2018
1	Primary Ovarian Insufficiency 01/2017
1	Wrist Fractures 01/2017
1	Neuromyelitis Optica (Devic's Disease) 12/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2016
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2016
1	Male Infertility (Male Sterility) 06/2015
1	Joint Diseases (Joint Disease) 06/2015
1	Arthritis (Polyarthritis) 06/2015
1	Uveitis 06/2014
1	Fibrous Dysplasia of Bone 04/2014
1	Bone Diseases (Bone Disease) 04/2014
1	hereditary expansile Polyostotic osteolytic dysplasia 04/2014

Drug/Important Bio-Agent (IBA)

18	AutoantigensIBA 03/2022 - 11/2006
17	AutoantibodiesIBA 01/2022 - 01/2005
10	AntigensIBA 03/2022 - 11/2006
7	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2008
5	Insulin (Novolin)FDA Link 01/2022 - 11/2017
5	EpitopesIBA 09/2021 - 01/2018
5	InterferonsIBA 03/2021 - 11/2007
4	Interferon Type IIBA 09/2021 - 11/2007
3	AntibodiesIBA 10/2020 - 11/2007
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2002
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 04/2014 - 01/2008
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 03/2022
1	Perilipin-1IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 03/2021
1	GemininIBA 01/2021
1	cyclopropapyrroloindoleIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	STAT1 Transcription FactorIBA 01/2021
1	Janus KinasesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 10/2020
1	EnzymesIBA 10/2020
1	Immunoglobulin M (IgM)IBA 10/2020
1	ImmunosorbentsIBA 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Sulfhydryl Compounds (Thiols)IBA 01/2020
1	DisulfidesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2020
1	Pancreatic Elastase (Elastase)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Mutant Proteins (Protein, Mutant)IBA 01/2019
1	TrypsinIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	SandIBA 01/2018
1	AIRE ProteinIBA 01/2017
1	formiminotetrahydrofolate cyclodeaminaseIBA 01/2017
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2017
1	Immune Checkpoint ProteinsIBA 01/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2016
1	Aquaporins (Water Channels)IBA 10/2016
1	ProteomeIBA 02/2016
1	transglutaminase 4IBA 06/2015
1	Carrier Proteins (Binding Protein)IBA 06/2015
1	Retinaldehyde (Retinal)IBA 06/2014
1	Protein Sorting Signals (Signal Peptide)IBA 04/2014
1	Codon (Codons)IBA 04/2014

Therapy/Procedure

4	Therapeutics 01/2020 - 09/2008
2	Immunotherapy 01/2022 - 01/2019
2	Glycemic Control 01/2020 - 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Replacement Arthroplasty 01/2020
1	Bone Wires 01/2017